Public Health
publicado em 19/06/2013 às 11h01:00
   Dê o seu voto:

Brazil becomes autosufiente in the production of vaccine against influenza A

The prediction is that the Butantan Institute to produce 44 million doses already in the vaccination campaign 2015

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



From 2015, Brazil will produce all the vaccine virus Influenza A needed to meet the national demand. For the campaign of 2013, the Butantan Institute, Brazilian manufacturer of vaccines, produced 15% of the total applied. The French laboratory Sanofi Pasteur transferred the technology that made it possible to manufacture. For vaccination in 2015 will be produced 44 million doses.

14 other biologics manufacturing will have 100% Brazilian, six for cancer (including breast cancer and leukemia), four for rheumatoid arthritis, one for diabetes, one healing, one growth hormone and a vaccine for allergy. According to the Ministry of Health, the economy with the production will be 225 million per year. Biological medicinal product, made from living material whose production involves molecular biology, next-generation products and high cost. The group represents 43% of government spending on medicines, U.S. $ 4 billion per year.

For manufacturing in Brazil, 27 partnerships were made with eight public and 17 private laboratories. Altogether, there are 90 such partnerships, which involve the transfer of technology 77 products. Among the drugs are L-asparaginase, used to treat acute leukemia, whose manufacturer announced in December that not only produce more and that was stock for the next six months. To the Minister of Health, Alexandre Padilha, the production of the drug in Brazil is safe for patients. The Trastuzumab is another remedy that will be produced in the country. Recently incorporated into the chart's Health System, used for the treatment of breast cancer.

The Ministry of Health announced that Brazil will be the first factory for the production of biological medicines from plant cell (carrot and tobacco), installed in Eusébio, Ceará. Construction is scheduled to begin in 2014 and should cost £ 170 million. Be made medicaments for the treatment of diseases and rare first vaccine in the world from a plant against yellow fever.

Source: AGÊNCIA BRASIL
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Brazil becomes autosufiente in the production of vaccine against influenza A
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Brazil becomes autosufiente in the production of vaccine against influenza A


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
self-sufficient in vaccine Influenza A vaccine against Influenza A    Influenza A    influenza vaccine in Brazil autosuficente flu vaccine    biologics    Sanofi Pasteur    Instituto Butantan   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.